Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Cangene Corporation

Below is an extended Cangene Corporation patents listing. Click here to return to the Cangene Corporation main Biocorporate entry.

Cangene Corporation Patents :

US Patent No.Title
6271344 Enhanced affinity hyaluronan binding peptides
5200327 Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces
5409818 Nucleic acid amplification process
5514590 Expression system comprising DNA encoding the signal peptide of protease B from Streptomyces griseus
5616485 Streptomyces proteases and improved streptomyces strains for expression of peptides and polypeptides
5641663 Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from steptomyces
5856166 Streptomyces proteases and methods for improved secretion of recombinantly-expressed proteins
5888774 Recombinant DNA molecules and expression vectors for erythropoietin
5985607 Recombinant DNA molecules and expression vectors for tissue plasminogen activator
5993812 Method of delaying the progression of an infection with the human immunodeficiency virus
6127144 Method for expression of proteins in bacterial host cells
5130238 Enhanced nucleic acid amplification process

«Cangene Corporation

This page contained an extended Cangene Corporation patents listing. Click here to return to the Cangene Corporation main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.